Norplant consensus statement and background review.
This review has highlighted the attributes of a very important new method of contraception. The signatories to this document agree that, with the provision of appropriate information and instruction for the user, Norplant is a good contraceptive choice to be made available worldwide in family planning programs that have the resources for appropriate training and counseling. The signatories to this document are acting in their own personal capacity and not as representatives of any particular organization.
Fraser
I S
IS
Department of Obstetrics and Gynaecology, University of Sydney, NSW, Australia.
Tiitinen
A
A
Affandi
B
B
Brache
V
V
Croxatto
H B
HB
Diaz
S
S
Ginsburg
J
J
Gu
S
S
Holma
P
P
Johansson
E
E
Meirik
O
O
Mishell
D R
DR
Nash
H A
HA
von Schoultz
B
B
Sivin
I
I
D003271:Contraceptive Agents, Female / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004343:Drug Implants; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D045167:Progesterone Congeners / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D003271:Contraceptive Agents, Female; D004343:Drug Implants; D045167:Progesterone Congeners; D016912:Levonorgestrel